Allergychoices began in 2000 as the first dedicated education, advocacy, and networking resource for patients and physicians who were interested in sublingual immunotherapy to treat the underlying cause of allergic disease in the U.S. It was founded by allergy providers who developed the La Crosse Method™ Protocol, based on decades of clinical experience at their Allergy Associates of La Crosse practice in Wisconsin. The outcomes from this protocol were recently validated by the Validation Institute (validationinstitute.com). Today, the company has grown to be a leading healthcare services company that provides tools that enable physicians across the U.S. to provide sublingual immunotherapy within patients’ reach, and gives allergy sufferers information and access to treatment options using custom sublingual immune therapy close to home.